While U.S. stocks closed little changed on Monday, there were some notable insider trades.
When insiders buy shares, it indicates that they have confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long the stock. Domestic purchases should not be considered the only indicator for making an investment or trading decision. At best, it can lend conviction to a purchasing decision.
Below is a look at some notable recent insider purchases. For more information, check it out Benzinga’s insider transactions platform.
Semtech
- The Commerce: Semtech Corporation SMTC Mark Lin, executive vice president and chief financial officer purchased a total of 1,000 shares an average price of $33.23. Buying these shares cost approximately $33,232.
- What is going on: On March 28, Semtech reported a loss for the fourth quarter.
- What Semtech does: Semtech Corp is engaged in the design, development, manufacturing and marketing of analog and mixed-signal semiconductors, wireless algorithms and semiconductors, connectivity modules, gateways, routers and connected services for the IoT.
Greif
- The Commerce: Greif, Inc. GEF Executive Vice President and General Counsel Gary R Martz acquired a total of 10,082 shares at an average price of $68.23. These shares cost approximately $687,932 to purchase.
- What is going on: On Feb. 28, Greif posted upbeat quarterly earnings.
- What Greif does: Greif Inc is a manufacturer of industrial packaging products and services with manufacturing facilities located in many countries.
Don’t forget to check out our pre-market coverage here
Zumiez
- The Commerce: Zumiez Inc. ZUMZ International President Adam Christopher Ellis purchased a total of 10,000 shares at an average price of $14.31. These shares cost approximately $143,100 to purchase.
- What is going on: On March 20, B. Riley Securities analyst Jeff Van Sinderen kept Zumiez with a neutral stance and lowered the price target from $19 to $16.
- What Zumiez does: Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories and durable goods.
Angiodynamics
- The Commerce: AngioDynamics, Inc. I intend President and CEO James C Clemmer purchased a total of 10,000 shares at an average price of $6.70. The insider spent about $67,000 to buy those shares.
- What is going on: On April 4, AngioDynamics received FDA 510(k) clearance for the AlphaVac F1885 Pulmonary Embolism System.
- What AngioDynamics does: AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers to treat peripheral vascular disease and for use in oncology and surgery.
Check it: Investor optimism improves; The Fear and Greed Index remains in the ‘greed’ zone
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.